Analysis of Urokinase-type Plasminogen Activator (uPA), Plasminogen Activator Inhibitor Type-1 (PAI-1), and Urokinase Plasminogen Activator Receptor (uPAR) Protein Expression by Immunohistochemistry in Triple-Negative Breast Cancer (TNBC)
- Weitere Titel
-
Untersuchung der Proteinexpression der Urokinase (uPA), des Plasminogen-Aktivator-Inhibitors Typ 1 (PAI-1) und des Urokinase-Rezeptors (uPAR) mittels Immunhistochemie im triple-negativen Mammakarzinom (TNBC)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Technische Universität München, Dissertation, 2020
- Schlagwort
-
Breast--Cancer
Expression
Plasminogen
Urokinase
Immunohistochemistry
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der TU München
- (wann)
-
2020
- Urheber
-
Kendziora, Elena Stephanie
- Beteiligte Personen und Organisationen
-
Magdolen, Viktor
Weichert, Wilko
- URN
-
urn:nbn:de:bvb:91-diss-20200128-1485545-1-8
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kendziora, Elena Stephanie
- Magdolen, Viktor
- Weichert, Wilko
- Universitätsbibliothek der TU München
Entstanden
- 2020
Ähnliche Objekte (12)
Urokinase-type plasminogen activator receptor in vascular calcification
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
Urokinase-type plasminogen activator receptor in vascular calcification
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
Urokinase-type plasminogen activator receptor in vascular calcification
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report
Regulation of the human urokinase type plasminogen activator receptor gene
Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator
In silico docking of urokinase plasminogen activator and integrins
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor
Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD